Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA ...
As of Wednesday, December 31, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 34.23%, which has investors ...
The FDA decision was based on results from three late-stage clinical studies, including two Phase 3 trials conducted in ...
Shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) rose sharply in pre-market after the company announced U.S. Food and Drug ...
Vanda Pharmaceuticals and the FDA have agreed to lay down their swords, squashing years of legal disputes with an agreement that will see regulatory action on much of Vanda’s grievances. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results